Wednesday, 5 May 2021
Webinar IRISCAT by Dra. Gemma Moncunill
SARS-CoV-2 seroprevalence and antibody kinetics
Knowledge about the seroprevalence of SARS-CoV-2 antibodies after natural infection or vaccination is crucial to understand the control of the pandemy. Seroprevalence follow up and factors defining kinetics of protection at population level will help to understand its impact.
GCAT project, through the COVICAT study, will give additional clues to current studies to understand immunity against SARS-CoV-2.
Next Wednesday, May 5 at 16.00 Dra. Gemma Moncunill from ISGLOBAL will talk about this topic at the next IRISCAT Webinar entitled "Seroprevalence and kinetics of SARS-CoV-2 antibodies" in a study carried out among health workers at the Hospital Clinic after six months of follow-up.